We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Development of an Urticaria Control Test (UCT-D)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01610128
First Posted: June 1, 2012
Last Update Posted: January 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
K. Weller, Charite University, Berlin, Germany
  Purpose
The aim of the project is to develop a patient reported outcome instrument to assess disease control in chronic urticaria patients (Urticaria Control Test - UCT) of age 12 and older.

Condition
Chronic Urticaria

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: UCT - Development of an Instrument to Assess Disease Control in Patients With Chronic Urticaria (Urticaria Control Test)

Resource links provided by NLM:


Further study details as provided by K. Weller, Charite University, Berlin, Germany:

Enrollment: 508
Study Start Date: October 2011
Study Completion Date: August 2013
Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
chronic urticaria patients
all patients suffering from chronic types of urticaria (chronic spontaneous urticaria as well as chronic inducible forms such as cold contact urticaria)

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
all patients suffering from chronic forms of urticaria
Criteria

Inclusion Criteria:

all patients suffering from chronic forms of urticaria are eligible

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01610128


Locations
Germany
Universitätshautklinik Mainz
Mainz, Rheinland-Pfalz, Germany, 55131
Allergie-Centrum-Charite
Berlin, Germany, 10117
Sponsors and Collaborators
Charite University, Berlin, Germany
  More Information

Responsible Party: K. Weller, Principal Investigator, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT01610128     History of Changes
Other Study ID Numbers: UCT-D
First Submitted: May 30, 2012
First Posted: June 1, 2012
Last Update Posted: January 6, 2017
Last Verified: January 2017

Keywords provided by K. Weller, Charite University, Berlin, Germany:
urticaria, patient reported outcome

Additional relevant MeSH terms:
Urticaria
Skin Diseases, Vascular
Skin Diseases
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases